{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:02:32Z","timestamp":1790704952672,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21NS088326-01A1"],"award-info":[{"award-number":["1R21NS088326-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HDTRA1-11-16 BRCWMC-BAA"],"award-info":[{"award-number":["HDTRA1-11-16 BRCWMC-BAA"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.virol.2018.10.021","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T14:04:23Z","timestamp":1541167463000},"page":"173-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats"],"prefix":"10.1016","volume":"526","author":[{"given":"Aaron W.","family":"Walters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Kujawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Albe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Klimstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2018.10.021_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/345671","article-title":"Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans","volume":"36","author":"Al-Hazmi","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2018.10.021_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4269\/ajtmh.2010.09-0293","article-title":"Risk factors for severe Rift Valley fever infection in Kenya, 2007","volume":"83","author":"Anyangu","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2018.10.021_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fcimb.2012.00105","article-title":"Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus","volume":"2","author":"Bales","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virol.2018.10.021_bib4","series-title":"Hunter's Tropical Medicine and Emerging Infectious Disease","first-page":"340","article-title":"Rift Valley Fever","author":"Bird","year":"2012"},{"key":"10.1016\/j.virol.2018.10.021_bib5","first-page":"3","article-title":"Severe human illness caused by rift valley fever virus in Mauritania, 2015","author":"Boushab","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.virol.2018.10.021_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2017.04.008","article-title":"Virus entry and replication in the brain precedes blood-brain barrier disruption during intranasal alphavirus infection","volume":"308","author":"Cain","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.virol.2018.10.021_bib7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3389\/fmicb.2015.01509","article-title":"Inflammatory biomarkers associated with lethal Rift Valley fever encephalitis in the Lewis Rat model","volume":"6","author":"Caroline","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2018.10.021_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jneuroim.2010.08.003","article-title":"Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis","volume":"230","author":"Casiraghi","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.virol.2018.10.021_bib9","doi-asserted-by":"crossref","first-page":"e2874","DOI":"10.1371\/journal.pntd.0002874","article-title":"Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model","volume":"8","author":"Dodd","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virol.2018.10.021_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2013.03.009","article-title":"Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge","volume":"98","author":"Gowen","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2018.10.021_bib11","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1128\/JVI.02341-13","article-title":"Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets","volume":"88","author":"Hartman","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.10.021_bib12","doi-asserted-by":"crossref","first-page":"e0003584","DOI":"10.1371\/journal.pntd.0003584","article-title":"Association of symptoms and severity of rift valley fever with genetic polymorphisms in human innate immune pathways","volume":"9","author":"Hise","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virol.2018.10.021_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12985-015-0392-3","article-title":"Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease","volume":"12","author":"Jansen van Vuren","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2018.10.021_bib14","doi-asserted-by":"crossref","first-page":"e0003548","DOI":"10.1371\/journal.pntd.0003548","article-title":"Factors associated with severe human Rift Valley fever in Sangailu, Garissa County, Kenya","volume":"9","author":"LaBeaud","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virol.2018.10.021_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.virol.2018.10.021_bib16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2018.10.021_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nri2971","article-title":"Illuminating viral infections in the nervous system","author":"McGavern","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virol.2018.10.021_bib18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0035-9203(79)90004-X","article-title":"The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizootic and virological studies","volume":"73","author":"Meegan","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2018.10.021_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4269\/ajtmh.2010.09-0318","article-title":"Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007","volume":"83","author":"Mohamed","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2018.10.021_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/cmdc.200500028","article-title":"An albumin-activated Far-Red fluorochrome for in\u2005vivo imaging","volume":"1","author":"Montet","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.virol.2018.10.021_bib21","doi-asserted-by":"crossref","first-page":"e0005582","DOI":"10.1371\/journal.pntd.0005582","article-title":"\u201cWe do not bury dead livestock like human beings\u201d: community behaviors and risk of Rift Valley Fever virus infection in Baringo County, Kenya","volume":"11","author":"Mutua","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virol.2018.10.021_bib22","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/tmi.12385","article-title":"Risk factors associated with human Rift Valley fever infection: systematic review and meta-analysis","volume":"19","author":"Nicholas","year":"2014","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.virol.2018.10.021_bib23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.medmal.2010.12.007","article-title":"Les formes graves de la fi\u00e8vre de la vall\u00e9e de Rift pendant l\u2032\u00e9pid\u00e9mie \u00e0 Madagascar","volume":"41","author":"Rakotoarivelo","year":"2011","journal-title":"M\u00e9d. Mal. Infect."},{"key":"10.1016\/j.virol.2018.10.021_bib24","doi-asserted-by":"crossref","first-page":"e2156","DOI":"10.1371\/journal.pntd.0002156","article-title":"Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development","volume":"7","author":"Reed","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virol.2018.10.021_bib25","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.3390\/v6103827","article-title":"Spread of Oropouche Virus into the central nervous system in mouse","volume":"6","author":"Santos","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2018.10.021_bib26","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1128\/JVI.05032-11","article-title":"The role of the blood-brain barrier during Venezuelan equine encephalitis virus infection","volume":"85","author":"Schafer","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.10.021_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.01.016","article-title":"Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment","volume":"104","author":"Scharton","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2018.10.021_bib28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jneuroim.2017.03.006","article-title":"Molecular mechanisms of neuroinflammation and injury during acute viral encephalitis","volume":"308","author":"Shives","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.virol.2018.10.021_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000335182","article-title":"Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB\/c mouse brain challenged with Japanese encephalitis virus","volume":"19","author":"Shukla","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.virol.2018.10.021_bib30","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/JVI.06190-11","article-title":"Development of a novel nonhuman primate model for Rift Valley fever","volume":"86","author":"Smith","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.10.021_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.virol.2010.08.016","article-title":"The pathogenesis of Rift Valley fever virus in the mouse model","volume":"407","author":"Smith","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.10.021_bib32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.virol.2009.10.036","article-title":"Reversal of West Nile virus-induced blood\u2013brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor","volume":"397","author":"Verma","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.10.021_bib33","doi-asserted-by":"crossref","first-page":"8978","DOI":"10.1128\/JVI.00314-08","article-title":"Matrix metalloproteinase 9 facilitates west nile virus entry into the brain","volume":"82","author":"Wang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.10.021_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00401-015-1433-0","article-title":"Capillaries in the olfactory bulb but not the cortex are highly susceptible to virus-induced vascular leak and promote viral neuroinvasion","volume":"130","author":"Winkler","year":"2015","journal-title":"Acta Neuropathol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218303337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218303337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:48:11Z","timestamp":1758588491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682218303337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":34,"alternative-id":["S0042682218303337"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2018.10.021","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2018.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}